These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2067357)

  • 1. Vagal cooling blocks circulating neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) release.
    Rudnicki M; Rigel DF; McFadden DW
    J Surg Res; 1991 Jul; 51(1):40-5. PubMed ID: 2067357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
    Wager-Pagé SA; Raizada E; Veale W; Davison JS
    Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
    Wager-Pagé SA; Rosenbaum G; Veale WL; Davison JS
    Peptides; 1993; 14(6):1299-308. PubMed ID: 8134313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peripheral modulation of duodenal and colonic motility in rats by the pancreatic polypeptide-fold family: neuropeptide Y, peptide YY, and pancreatic polypeptide.
    Wager-Pagé SA; Ghazali B; Anderson W; Veale WL; Davison JS
    Peptides; 1993; 14(2):153-60. PubMed ID: 8483795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
    Chen CH; Stephens RL; Rogers RC
    Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vagal blockade on food- and hormone-stimulated release of pancreatic polypeptide and motilin in dogs.
    Greenberg GR; Chan B; Nordgren SR; Alleyne J
    Dig Dis Sci; 1985 Oct; 30(10):946-53. PubMed ID: 4028911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucose on circulating and ileal intraluminal peptide YY and pancreatic polypeptide release.
    Rudnicki M; McFadden DW; Kuvshinoff BW; Dayal R; Fischer JE
    Am J Surg; 1991 Sep; 162(3):268-70. PubMed ID: 1928591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural regulation of peptide YY secretion.
    Zhang T; Uchida T; Gomez G; Lluis F; Thompson JC; Greeley GH
    Regul Pept; 1993 Nov; 48(3):321-8. PubMed ID: 8278624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
    Lüers C; Gardemann A; Miura H; Jungermann K
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.
    Holzer P; Reichmann F; Farzi A
    Neuropeptides; 2012 Dec; 46(6):261-74. PubMed ID: 22979996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and release of peptide YY in dog measured by specific radioimmunoassay.
    Taylor IL
    Gastroenterology; 1985 Mar; 88(3):731-7. PubMed ID: 3838162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: involvement of the cholinergic nervous system.
    Wager-Pagé SA; Raizada E; Veale WL; Davison JS
    Can J Physiol Pharmacol; 1993 Feb; 71(2):112-9. PubMed ID: 8319134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.
    Larhammar D
    Regul Pept; 1996 Apr; 62(1):1-11. PubMed ID: 8738876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between innate cytokines and the pancreatic polypeptide family in acute pancreatitis.
    Pendharkar SA; Singh RG; Petrov MS
    Cytokine; 2017 Feb; 90():161-168. PubMed ID: 27918953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunohistochemical and biochemical analysis of pancreatic polypeptide-like peptides with special reference to presence of neuropeptide Y in central and peripheral neurons.
    Lundberg JM; Terenius L; Hökfelt T; Tatemoto K
    J Neurosci; 1984 Sep; 4(9):2376-86. PubMed ID: 6548255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.
    Ballantyne GH
    Obes Surg; 2006 May; 16(5):651-8. PubMed ID: 16687037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line.
    Cox HM; Tough IR
    Br J Pharmacol; 1995 Nov; 116(6):2673-8. PubMed ID: 8590988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice.
    Nakajima M; Inui A; Teranishi A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1010-4. PubMed ID: 8113957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.